Mirtazapine
Product Images NDC 64725-0247

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 64725-0247). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tya Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (64725 0247)

Label for Mirtazapine 15 mg tablets, indicating a bottle of 30 tablets. The label includes RX only designation, a barcode, manufacturer listed as Apotex, and notes repackaging by TYA Pharmaceuticals with an address in Tallahassee, FL. The label advises to see package insert for dosing information.*

FDA Label Image

Structure (Structure)

Chemical structure of Mirtazapine, showing its tetracyclic ring system including three benzene rings and nitrogen atoms, representing the active ingredient in the product by TYA Pharmaceuticals.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.